STANDARD BIOTOOLS INC (LAB:NASDAQ)
$0.6894 0.0191 (2.8495%)
Analysed STANDARD BIOTOOLS INC (LAB:NASDAQ) News Sources
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
21-04-2026
yahoo.com
Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is Why
14-04-2026
yahoo.com
Standard BioTools Reports First Quarter 2026 Financial Results
05-05-2026
yahoo.com
Standard BioTools and Treeline Biosciences Announce Merger Agreement
08-06-2026
yahoo.com
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
20-07-2026
yahoo.com
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
28-07-2026
yahoo.com
Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences
28-07-2026
yahoo.com
Standard BioTools Reports Second Quarter 2026 Financial Results
05-08-2026
yahoo.com
Standard BioTools Provides Update on Sale of Mass Cytometry Business
30-09-2026
yahoo.com
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
05-10-2026
yahoo.com
What is the current price of STANDARD BIOTOOLS INC (LAB:NASDAQ)?
The current price of STANDARD BIOTOOLS INC (LAB:NASDAQ) is $0.6894.
STANDARD BIOTOOLS INC (LAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of STANDARD BIOTOOLS INC (LAB:NASDAQ) since the previous trading day is $0.0191.
STANDARD BIOTOOLS INC (LAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of STANDARD BIOTOOLS INC (LAB:NASDAQ) since the previous trading day is 2.8495%.
What is the most recent average sentiment score for STANDARD BIOTOOLS INC (LAB:NASDAQ)?
The most recent average sentiment score for STANDARD BIOTOOLS INC (LAB:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for STANDARD BIOTOOLS INC (LAB:NASDAQ)?
The most recent sentiment for STANDARD BIOTOOLS INC (LAB:NASDAQ) is .
SEC-8K** Filing Available For STANDARD BIOTOOLS INC (LAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.